BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 35790550)

  • 1. Mapping DEHP to the adverse outcome pathway network for human female reproductive toxicity.
    Pogrmic-Majkic K; Samardzija Nenadov D; Tesic B; Fa Nedeljkovic S; Kokai D; Stanic B; Andric N
    Arch Toxicol; 2022 Oct; 96(10):2799-2813. PubMed ID: 35790550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associating diethylhexyl phthalate to gestational diabetes mellitus via adverse outcome pathways using a network-based approach.
    Zhang T; Wang S; Li L; Zhu A; Wang Q
    Sci Total Environ; 2022 Jun; 824():153932. PubMed ID: 35182638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of a derived adverse outcome pathway (AOP) network for endocrine-mediated perturbations.
    Ravichandran J; Karthikeyan BS; Samal A
    Sci Total Environ; 2022 Jun; 826():154112. PubMed ID: 35219661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a putative adverse outcome pathway network for male rat reproductive tract abnormalities with specific considerations for the androgen sensitive window of development.
    Palermo CM; Foreman JE; Wikoff DS; Lea I
    Curr Res Toxicol; 2021; 2():254-271. PubMed ID: 34401750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrative data-centric approach to derivation and characterization of an adverse outcome pathway network for cadmium-induced toxicity.
    Sahoo AK; Chivukula N; Ramesh K; Singha J; Marigoudar SR; Sharma KV; Samal A
    Sci Total Environ; 2024 Apr; 920():170968. PubMed ID: 38367714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative Data Mining Approach: Case Study with Adverse Outcome Pathway Network Leading to Pulmonary Fibrosis.
    Jeong J; Kim D; Choi J
    Chem Res Toxicol; 2023 Jun; 36(6):838-847. PubMed ID: 37093963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linking nanomaterial-induced mitochondrial dysfunction to existing adverse outcome pathways for chemicals.
    Murugadoss S; Vinković Vrček I; Schaffert A; Paparella M; Pem B; Sosnowska A; Stępnik M; Martens M; Willighagen EL; Puzyn T; Roxana Cimpan M; Lemaire F; Mertens B; Dusinska M; Fessard V; Hoet PH
    ALTEX; 2024 Jan; 41(1):76-90. PubMed ID: 37606097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse outcome pathways (AOPs) for radiation-induced reproductive effects in environmental species: state of science and identification of a consensus AOP network.
    Tollefsen KE; Alonzo F; Beresford NA; Brede DA; Dufourcq-Sekatcheff E; Gilbin R; Horemans N; Hurem S; Laloi P; Maremonti E; Oughton D; Simon O; Song Y; Wood MD; Xie L; Frelon S
    Int J Radiat Biol; 2022; 98(12):1816-1831. PubMed ID: 35976054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AOP-helpFinder webserver: a tool for comprehensive analysis of the literature to support adverse outcome pathways development.
    Jornod F; Jaylet T; Blaha L; Sarigiannis D; Tamisier L; Audouze K
    Bioinformatics; 2022 Jan; 38(4):1173-1175. PubMed ID: 34718414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A toxicity pathway-oriented approach to develop adverse outcome pathway: AHR activation as a case study.
    Jin Y; Feng M; Ma W; Wei Y; Qi G; Luo J; Xu L; Li X; Li C; Wang Y; Li D; Chen J; Zhao Y; Hou Y; Zhao Q; Jiang L; Xie M; Zheng Y; Yu D
    Environ Pollut; 2021 Jan; 268(Pt B):115733. PubMed ID: 33011576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generating adverse outcome pathway (AOP) of inorganic arsenic-induced adult male reproductive impairment via integration of phenotypic analysis in comparative toxicogenomics database (CTD) and AOP wiki.
    Chai Z; Zhao C; Jin Y; Wang Y; Zou P; Ling X; Yang H; Zhou N; Chen Q; Sun L; Chen W; Ao L; Cao J; Liu J
    Toxicol Appl Pharmacol; 2021 Jan; 411():115370. PubMed ID: 33338516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building an adverse outcome pathway network for estrogen-, androgen- and steroidogenesis-mediated reproductive toxicity.
    Zilliacus J; Draskau MK; Johansson HKL; Svingen T; Beronius A
    Front Toxicol; 2024; 6():1357717. PubMed ID: 38601197
    [No Abstract]   [Full Text] [Related]  

  • 13. Linking Bisphenol S to Adverse Outcome Pathways Using a Combined Text Mining and Systems Biology Approach.
    Carvaillo JC; Barouki R; Coumoul X; Audouze K
    Environ Health Perspect; 2019 Apr; 127(4):47005. PubMed ID: 30994381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying the adverse outcome pathway concept for assessing non-monotonic dose responses: biphasic effect of bis(2-ethylhexyl) phthalate (DEHP) on testosterone levels.
    Astuto MC; Benford D; Bodin L; Cattaneo I; Halldorsson T; Schlatter J; Sharpe RM; Tarazona J; Younes M
    Arch Toxicol; 2023 Feb; 97(2):313-327. PubMed ID: 36336711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an adverse outcome pathway network for nephrotoxicity.
    Barnes DA; Firman JW; Belfield SJ; Cronin MTD; Vinken M; Janssen MJ; Masereeuw R
    Arch Toxicol; 2024 Mar; 98(3):929-942. PubMed ID: 38197913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a data-driven approach to Adverse Outcome Pathway network generation: a case study on the EATS-modalities.
    Wiklund L; Caccia S; Pípal M; Nymark P; Beronius A
    Front Toxicol; 2023; 5():1183824. PubMed ID: 37229356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing adverse outcome pathways on silver nanoparticle-induced reproductive toxicity via oxidative stress in the nematode Caenorhabditis elegans using a Bayesian network model.
    Jeong J; Song T; Chatterjee N; Choi I; Cha YK; Choi J
    Nanotoxicology; 2018 Dec; 12(10):1182-1197. PubMed ID: 30663905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semantic characterization of adverse outcome pathways.
    Wang RL
    Aquat Toxicol; 2020 May; 222():105478. PubMed ID: 32278258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrative systems biology strategy to support the development of adverse outcome pathways (AOPs): a case study on radiation-induced microcephaly.
    Jaylet T; Quintens R; Armant O; Audouze K
    Front Cell Dev Biol; 2023; 11():1197204. PubMed ID: 37427375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a combined aggregate exposure pathway and adverse outcome pathway (AEP-AOP) approach to inform a cumulative risk assessment: A case study with phthalates.
    Clewell RA; Leonard JA; Nicolas CI; Campbell JL; Yoon M; Efremenko AY; McMullen PD; Andersen ME; Clewell HJ; Phillips KA; Tan YM
    Toxicol In Vitro; 2020 Aug; 66():104855. PubMed ID: 32278033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.